“Little Big Things is all about connecting the Parkinson’s community directly with the people working to solve problems and address issues our community faces through creative thinking, new technologies and advocacy," says Jenna Deidel, with the Davis Phinney Foundation.
AUSTIN, Texas (PRWEB) October 08, 2019
A free, interactive event highlighting innovations and ideas helping people with Parkinson’s live well will be held this month in Austin, Texas. The event, featuring thought leaders, innovators and health experts, will display innovations that could help people with Parkinson’s disease live better today.
Held from 2:00 p.m. to 5:30 p.m. CT on October 19 at the Coppertank Event Center in Austin, the event is co-hosted by the Davis Phinney Foundation and Sunovion. Innovations and technology have a major impact on people with Parkinson’s and can help people cope with issues around movement, eating, transportation, independence and even receiving critical care from specialists.
Little Big Things is a community with a mission to spark, share and celebrate the little innovations that could have a big impact on people living with Parkinson’s, created by Sunovion.
“There are so many amazing ideas, big and small, that can change how people live with Parkinson’s,” says Jenna Deidel, the Director of Programs & Outreach at the Davis Phinney Foundation. “Little Big Things is all about connecting the Parkinson’s community directly with the people working to solve problems and address issues our community faces through creative thinking, new technologies and advocacy.”
“Sunovion is committed to fostering innovation to help make a difference for those living with Parkinson’s,” said Emily K. Bulat, Executive Director, Neurology Marketing, at Sunovion. “We are proud to partner with the Davis Phinney Foundation to host this dynamic Little Big Things event to raise awareness of the many innovations, big and small, that could have an impact on the Parkinson’s community.”
From renowned healthcare providers to people with deep connections to Parkinson’s, Sunovion and the Davis Phinney Foundation are pleased to present several notable speakers, including:
- John Dean, Speech Language Pathologist and CEO of Triad Health, will talk about using smart speakers to create thoughtful exercise routines for Parkinson’s
- Ray Dorsey, Movement Disorder Specialist at the University of Rochester Medical Center will talk about his work in making Parkinson’s care available to everyone everywhere
- Tim Hague, an author and inspirational speaker will talk about his path with Parkinson’s and how it turned him into a community activist
In addition to hearing from these speakers, and others, guests of the event will also have a chance to meet with innovators in the Exhibit Hall who will present tools and technology available right now to help people live well with Parkinson’s today including SpeechVive, Calibrace+, Naboso Technology and many more.
The Davis Phinney Foundation was founded by Olympic cyclist Davis Phinney in 2004 to help people with Parkinson’s live well today. The organization’s focus is to provide programs and resources that offer inspiration, information and tools that enable people living with Parkinson’s to take action that can immediately improve their quality of life. Parkinson’s is the No. 2 neurodegenerative disease– second only to Alzheimer’s – and affects more than 1 million people in the United States. The Foundation’s work impacts hundreds of thousands of individuals and families each year. It is headquartered in Louisville, Colo.
Sunovion Pharmaceuticals Inc. (Sunovion) Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s vision is to lead the way to a healthier world. The company’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. With patients at the center of everything it does, Sunovion has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological and respiratory conditions.
Headquartered in Marlborough, Mass., Sunovion is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc. Additional information can be found on the company’s websites: http://www.sunovion.com, http://www.sunovion.eu, and http://www.sunovion.ca.